In our study, correlations of SPP1, COL1A2, IGF1, LPA, and LGALS3 with patient prognosis highlight the importance of these five genes as potential biomarkers to stratify HCC patients as well as potential therapeutic targets, but concrete roles of these genes need further investigation. This evidence concerns the gene LPA and hepatocellular carcinoma.